PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-Jan-2020 Ionis' neurological franchise marks year of achievement Ionis Pharmaceuticals, Inc.
07-Jan-2020 Actinium Pharmaceuticals, Inc. to Present at 2020 Biotech Showcase(TM) Actinium Pharmaceuticals, Inc.
07-Jan-2020 Protagonist Therapeutics Achieves Milestone in Janssen Biotech, Inc., Collaboration Protagonist Therapeutics, Inc.
07-Jan-2020 IceCure Receives FDA Clearance for Expanded Indications of Cryoablation Technology and Regulatory Approval of New MultiSense System; Plans to Increase U.S. Presence and Operations IceCure Medical
07-Jan-2020 Innovation Introduces New Leadership Team to Industry Innovation
07-Jan-2020 Polyganics Achieves CE Mark Certification for LIQOSEAL® B3C newswire
07-Jan-2020 4SC AG enters into avelumab supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer for clinical combination study of domatinostat in Merkel cell carcinoma 4SC AG
07-Jan-2020 Xlife Sciences AG: Velabs Therapeutics receives exclusive licence from alytas therapeutics for the development of therapeutic antibodies as senolytics Xlife Sciences AG
07-Jan-2020 EVOTEC AND BRISTOL-MYERS SQUIBB EXPAND IPSC COLLABORATION Evotec SE
07-Jan-2020 Velabs Therapeutics Receives Exclusive Licence from Alytas Therapeutics for the Development of Therapeutic Antibodies as Senolytics B3C newswire
07-Jan-2020 Vivoryon Therapeutics AG: Vivoryon Therapeutics to Attend 38th Annual J.P. Morgan Healthcare Conference in January 2020 Vivoryon Therapeutics AG
07-Jan-2020 Japanese Clinical Study of DiscGenics' Cell Therapy for Disc Degeneration Passes Initial Safety Review DiscGenics, Inc.
06-Jan-2020 BioNJ Announces the 2020 Innovator Award Honorees BioNJ
06-Jan-2020 Canavation Product Group Acquires Bio Lab Naturals Canavation Product Group
06-Jan-2020 Biofrontera AG: Biofrontera strengthens commercial focus with reorganization of its US business Biofrontera AG
06-Jan-2020 Ionis Pharmaceuticals to present at 38th annual J.P. Morgan Healthcare Conference Ionis Pharmaceuticals, Inc.
06-Jan-2020 BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Merck
06-Jan-2020 Protagonist Therapeutics Initiates Phase 2 Study of Novel Hepcidin Mimetic PTG-300 in the Treatment of Patients with Hereditary Hemochromatosis Protagonist Therapeutics, Inc.
06-Jan-2020 CollPlant Partners in the Advanced Regenerative Manufacturing Institute CollPlant
06-Jan-2020 Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer Antengene Corporation